公司資料
Viatris Inc. 股價、新聞與催化劑
- 股票代碼:
- VTRS
- 交易所:
- NASDAQ
- 產業:
- Generics, Small Molecule Drugs
- 所在地:
- United States
股票表現
17.46 USD (-1.47%)
收盤價
最後更新: 2026年10月1日
18.3B USD
市值
股價為何變動
截至 2026年10月1日，VTRS 下跌 1.47%，收於 $17.46。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
Global Medicines Company
Viatris is a global healthcare company that develops, manufactures, and commercializes branded medicines, generic drugs, complex products, and biosimilars. Its portfolio is distributed across developed and emerging markets through a broad manufacturing, regulatory, and commercial network.
Established Brands Portfolio
The company's established brands include medicines used in cardiovascular disease, central nervous system disorders, respiratory disease, infectious disease, and other chronic conditions. These products often rely on geographic expansion, lifecycle management, and durable physician familiarity rather than exclusively on new molecular innovation.
Generics and Complex Products
Viatris manufactures oral solids, injectables, transdermal products, respiratory medicines, and other technically complex dosage forms. Scale in development, manufacturing, and regulatory submissions allows the company to supply a wide range of affordable medicines across multiple regions.
Biosimilars Business
The biosimilars portfolio gives Viatris exposure to large biologic markets through products referencing established therapies in oncology, immunology, diabetes, and other specialties. Commercialization is frequently conducted through regional partnerships that divide development, manufacturing, and market responsibilities.
Pipeline and Portfolio Management
Viatris combines internal development with licensing, partnerships, acquisitions, and divestitures to reshape its portfolio. New products include Gwyn Lo, while MR-107A-02 is being developed as a fast-acting, non-opioid meloxicam formulation for moderate-to-severe acute pain.
未來催化劑
- Commercial availability of Gwyn Lo later in 2026.
- FDA PDUFA decision for MR-107A-02 in moderate-to-severe acute pain on December 27, 2026.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。